DPP4 and synovial sarcoma: Pierson et al. demonstrated that a decreased CD26 expression is a useful diagnostic marker of peripheral blood involvement in SS and MF patients, but they have also emphasized that reactive T cells in tissue and body fluid specimens often show low levels of CD26 expression; thus this marker should be used in combination with others, in order to facilitate the diagnosis process [33].